FDA Adverse Event Malfunction Summary report: N

ARCHITECT CYCLOSPORINE

MDR report key: 2421967 · Received January 19, 2012

Report

Report Number
1415939-2012-00015
Event Type
Malfunction
Date Received
January 19, 2012
Date of Event
January 11, 2012
Report Date
January 12, 2012
Manufacturer
ABBOTT LABORATORIES
Product Code
MKW
PMA / PMN Number
K080751
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AR, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE. (B)(4).

Additional Manufacturer Narrative · 1

NO RETURNED MATERIALS FROM THE CUSTOMER SITE WERE USED DURING THIS EVALUATION. A PRECISION RUN WAS PERFORMED WITH REAGENT LOT 07011M500. (B)(4). AN ACCURACY RUN WAS ALSO PERFORMED USING TWO SEPARATE LOTS OF PANEL SAMPLES (LOTS AAM223 AND AAC442). ALL GENERATED VALUES MET ACCEPTANCE CRITERIA FOR THEIR RESPECTIVE MEAN FOR EACH LOT. A REVIEW OF COMPLAINT TRACKING AND TRENDING METRICS WAS PERFORMED AND IDENTIFIED NO ADVERSE TRENDS IN CONJUNCTION WITH THE COMPLAINT ISSUE CURRENTLY UNDER EVALUATION. THE ARCHITECT CYCLOSPORINE ASSAY PACKAGE INSERT CONTAINS INFORMATION TO ADDRESS THE CUSTOMER'S CURRENT ISSUE. BASED ON THE RESULTS OF THE CURRENT EVALUATION, THE ARCHITECT CYCLOSPORINE ASSAY IS PERFORMING AS INTENDED AND NO ADDITIONAL PRODUCT ISSUES WERE FOUND. A PRODUCT DEFICIENCY WAS NOT IDENTIFIED.

Description of Event or Problem · 1

THE CUSTOMER STATES THAT ONE PATIENT SAMPLE GENERATED ARCHITECT CYCLOSPORINE ASSAY RESULTS OF 120, 175, AND 145 NG/ML. THERE IS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT CYCLOSPORINE MKW ABBOTT LABORATORIES 07011M500

Patients

Seq Age Sex Outcome Treatment
1 ARCH I2000SR LN: 03M75-02 SN: (B)(4)| ARCH I2000SR LN: 03M75-02 SN: (B)(4)